In general, prostate cancer is diagnosed on needle-biopsies prompted by elevated serum prostate specific antigen (PSA) levels, suspicious digital rectal examination or trans-rectal ultrasonography findings, and/or clinical symptoms of urinary tract obstruction. This evidence concerns the gene KLK3 and prostate cancer.